Skip to content
Home/Companies/Healthcare/Exeliom Biosciences
Exeliom Biosciences

Exeliom Biosciences

Healthcare·France·Active·9yr hold
Entry
2017
Hold
9yr
Status
Active

Who owns Exeliom Biosciences?

Exeliom Biosciences is currently owned by Capital Grand Est through Cap Innov'Est 1 (2014 vintage), since 2017.

Hand-verified · updated 2026-04-21

Capital Grand Est
Investor
Capital Grand Est
Cap Innov'Est 1 · 2014 · VC

Key facts

HQFrance
SectorHealthcare
Websitewww.exeliombio.com

More from Cap Innov'Est 1

Other portfolio companies in the same fund.

AdipoPharma
AdipoPharma
Active
HealthcareFrance
Synovo
Synovo
Exited
Business ServicesFrance
to
Urania Therapeutics
Active
HealthcareFrance· 2020
Syndivia
Syndivia
Active
HealthcareFrance· 2019
TSA Industrie
TSA Industrie
Exited 2025
IndustrialsFrance· 2018
to
HipTest
Exited 2018
TMTFrance· 2016
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Track Exeliom Biosciences

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Exeliom Biosciences?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Exeliom Biosciences.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue